<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"><channel><title>tamoxifen</title><link>http://www.unboundmedicine.com/medline/ebm/research/tamoxifen</link><description>Unbound MEDLINE is a service provided by Unbound Medicine, Inc. that includes data and services from the U.S. National Library of Medicine's MEDLINE® and PubMed® databases.</description><language>en-us</language><copyright>Unbound Medicine, Inc.</copyright><item><title>Nuclear IRS-1 predicts tamoxifen response in patients with early breast cancer.</title><link>http://www.unboundmedicine.com/medline/ebm/record/19924529/full_citation/Nuclear_IRS_1_predicts_tamoxifen_response_in_patients_with_early_breast_cancer_</link><description>Migliaccio I, Wu MF, Gutierrez C, et al. <br/><span class="title">Nuclear IRS-1 predicts tamoxifen response in patients with early breast cancer. [JOURNAL ARTICLE]</span><br/><span class="source" title="Breast cancer research and treatment">Breast Cancer Res Treat 2009 Nov 19.</span><br/> <a href="http://www.unboundmedicine.com/medline/ebm/record/19924529/abstract/Nuclear_IRS_1_predicts_tamoxifen_response_in_patients_with_early_breast_cancer_">Abstract</a> | <a href="http://www.unboundmedicine.com/medline/ebm/record/19924529/full_citation/Nuclear_IRS_1_predicts_tamoxifen_response_in_patients_with_early_breast_cancer_">Full Citation</a></description></item><item><title>New Mouse Lines for the Analysis of Neuronal Morphology Using CreER(T)/loxP-Directed Sparse Labeling.</title><link>http://www.unboundmedicine.com/medline/ebm/record/19924248/full_citation/New_Mouse_Lines_for_the_Analysis_of_Neuronal_Morphology_Using_CreER_T_/loxP_Directed_Sparse_Labeling_</link><description>Badea TC, Hua ZL, Smallwood PM, et al. <br/><span class="title">New Mouse Lines for the Analysis of Neuronal Morphology Using CreER(T)/loxP-Directed Sparse Labeling. [JOURNAL ARTICLE]</span><br/><span class="source" title="PloS one">PLoS One 2009; 4(11):e7859.</span><br/> <a href="http://www.unboundmedicine.com/medline/ebm/record/19924248/abstract/New_Mouse_Lines_for_the_Analysis_of_Neuronal_Morphology_Using_CreER_T_/loxP_Directed_Sparse_Labeling_">Abstract</a> | <a href="http://www.unboundmedicine.com/medline/ebm/record/19924248/full_citation/New_Mouse_Lines_for_the_Analysis_of_Neuronal_Morphology_Using_CreER_T_/loxP_Directed_Sparse_Labeling_">Full Citation</a> | <a rel="nofollow" href="http://www.unboundmedicine.com/medline/ebm/related/19924248/New_Mouse_Lines_for_the_Analysis_of_Neuronal_Morphology_Using_CreER_T_/loxP_Directed_Sparse_Labeling_">Find Related Articles</a> </description></item><item><title>Declining recurrence among ductal carcinoma in situ patients treated with breast-conserving surgery in the community setting.</title><link>http://www.unboundmedicine.com/medline/ebm/record/19922614/full_citation/Declining_recurrence_among_ductal_carcinoma_in_situ_patients_treated_with_breast_conserving_surgery_in_the_community_setting_</link><description>Habel LA, Achacoso NS, Haque R, et al. <br/><span class="title">Declining recurrence among ductal carcinoma in situ patients treated with breast-conserving surgery in the community setting. [JOURNAL ARTICLE]</span><br/><span class="source" title="Breast cancer research : BCR">Breast Cancer Res 2009 Nov 18; 11(6):R85.</span><br/> <a href="http://www.unboundmedicine.com/medline/ebm/record/19922614/abstract/Declining_recurrence_among_ductal_carcinoma_in_situ_patients_treated_with_breast_conserving_surgery_in_the_community_setting_">Abstract</a> | <a href="http://www.unboundmedicine.com/medline/ebm/record/19922614/full_citation/Declining_recurrence_among_ductal_carcinoma_in_situ_patients_treated_with_breast_conserving_surgery_in_the_community_setting_">Full Citation</a> | <a rel="nofollow" href="http://www.unboundmedicine.com/medline/ebm/related/19922614/Declining_recurrence_among_ductal_carcinoma_in_situ_patients_treated_with_breast_conserving_surgery_in_the_community_setting_">Find Related Articles</a> </description></item><item><title>[A Case of Premenopausal Metastatic Breast Cancer Treated with Goserelin Plus Aromatase Inhibitor as Second-Line Endocrine Therapy.]</title><link>http://www.unboundmedicine.com/medline/ebm/record/19920398/full_citation/[A_Case_of_Premenopausal_Metastatic_Breast_Cancer_Treated_with_Goserelin_Plus_Aromatase_Inhibitor_as_Second_Line_Endocrine_Therapy_]</link><description>Baba S, Oji Y, Teramoto M, et al. <br/><span class="title">[A Case of Premenopausal Metastatic Breast Cancer Treated with Goserelin Plus Aromatase Inhibitor as Second-Line Endocrine Therapy.] [JOURNAL ARTICLE]</span><br/><span class="source" title="Gan to kagaku ryoho. Cancer &amp; chemotherapy">Gan To Kagaku Ryoho 2009 Nov; 36(11):1905-1906.</span><br/> <a href="http://www.unboundmedicine.com/medline/ebm/record/19920398/abstract/[A_Case_of_Premenopausal_Metastatic_Breast_Cancer_Treated_with_Goserelin_Plus_Aromatase_Inhibitor_as_Second_Line_Endocrine_Therapy_]">Abstract</a> | <a href="http://www.unboundmedicine.com/medline/ebm/record/19920398/full_citation/[A_Case_of_Premenopausal_Metastatic_Breast_Cancer_Treated_with_Goserelin_Plus_Aromatase_Inhibitor_as_Second_Line_Endocrine_Therapy_]">Full Citation</a></description></item><item><title>Systematic Review: Comparative Effectiveness of Medications to Reduce Risk for Primary Breast Cancer.</title><link>http://www.unboundmedicine.com/medline/ebm/record/19920271/full_citation/Systematic_Review:_Comparative_Effectiveness_of_Medications_to_Reduce_Risk_for_Primary_Breast_Cancer_</link><description>Nelson HD, Fu R, Griffin JC, et al. <br/><span class="title">Systematic Review: Comparative Effectiveness of Medications to Reduce Risk for Primary Breast Cancer. [JOURNAL ARTICLE]</span><br/><span class="source" title="Annals of internal medicine">Ann Intern Med 2009 Nov 17; 151(10):703-715.</span><br/> <a href="http://www.unboundmedicine.com/medline/ebm/record/19920271/abstract/Systematic_Review:_Comparative_Effectiveness_of_Medications_to_Reduce_Risk_for_Primary_Breast_Cancer_">Abstract</a> | <a href="http://www.unboundmedicine.com/medline/ebm/record/19920271/full_citation/Systematic_Review:_Comparative_Effectiveness_of_Medications_to_Reduce_Risk_for_Primary_Breast_Cancer_">Full Citation</a> | <a href="http://www.annals.org/cgi/pmidlookup%3fview=long%26amp;pmid=19920271">Publisher Full Text</a> | <a rel="nofollow" href="http://www.unboundmedicine.com/medline/ebm/related/19920271/Systematic_Review:_Comparative_Effectiveness_of_Medications_to_Reduce_Risk_for_Primary_Breast_Cancer_">Find Related Articles</a> </description></item><item><title>Tamoxifen-Poly(ethylene glycol)-Thiol Gold Nanoparticle Conjugates: Enhanced Potency and Selective Delivery for Breast Cancer Treatment.</title><link>http://www.unboundmedicine.com/medline/ebm/record/19919059/full_citation/Tamoxifen_Poly_ethylene_glycol__Thiol_Gold_Nanoparticle_Conjugates:_Enhanced_Potency_and_Selective_Delivery_for_Breast_Cancer_Treatment_</link><description>Dreaden EC, Mwakwari SC, Sodji QH, et al. <br/><span class="title">Tamoxifen-Poly(ethylene glycol)-Thiol Gold Nanoparticle Conjugates: Enhanced Potency and Selective Delivery for Breast Cancer Treatment. [JOURNAL ARTICLE]</span><br/><span class="source" title="Bioconjugate chemistry">Bioconjug Chem 2009 Nov 17.</span><br/> <a href="http://www.unboundmedicine.com/medline/ebm/record/19919059/abstract/Tamoxifen_Poly_ethylene_glycol__Thiol_Gold_Nanoparticle_Conjugates:_Enhanced_Potency_and_Selective_Delivery_for_Breast_Cancer_Treatment_">Abstract</a> | <a href="http://www.unboundmedicine.com/medline/ebm/record/19919059/full_citation/Tamoxifen_Poly_ethylene_glycol__Thiol_Gold_Nanoparticle_Conjugates:_Enhanced_Potency_and_Selective_Delivery_for_Breast_Cancer_Treatment_">Full Citation</a> | <a rel="nofollow" href="http://www.unboundmedicine.com/medline/ebm/related/19919059/Tamoxifen_Poly_ethylene_glycol__Thiol_Gold_Nanoparticle_Conjugates:_Enhanced_Potency_and_Selective_Delivery_for_Breast_Cancer_Treatment_">Find Related Articles</a> </description></item><item><title>[Cost-effectiveness analysis of adjuvant anastrozol in post-menopausal women with breast cancer.]</title><link>http://www.unboundmedicine.com/medline/ebm/record/19918652/full_citation/[Cost_effectiveness_analysis_of_adjuvant_anastrozol_in_post_menopausal_women_with_breast_cancer_]</link><description>Sasse AD, Sasse EC <br/><span class="title">[Cost-effectiveness analysis of adjuvant anastrozol in post-menopausal women with breast cancer.] [English Abstract, Journal Article]</span><br/><span class="source" title="Revista da Associação Médica Brasileira (1992)">Rev Assoc Med Bras 2009 Sep-Oct; 55(5):535-40.</span><br/> <a href="http://www.unboundmedicine.com/medline/ebm/record/19918652/abstract/[Cost_effectiveness_analysis_of_adjuvant_anastrozol_in_post_menopausal_women_with_breast_cancer_]">Abstract</a> | <a href="http://www.unboundmedicine.com/medline/ebm/record/19918652/full_citation/[Cost_effectiveness_analysis_of_adjuvant_anastrozol_in_post_menopausal_women_with_breast_cancer_]">Full Citation</a></description></item><item><title>Role of ldb1 in adult intestinal homeostasis.</title><link>http://www.unboundmedicine.com/medline/ebm/record/19918297/full_citation/Role_of_ldb1_in_adult_intestinal_homeostasis_</link><description>Dey-Guha I, Mukhopadhyay M, Phillips M, et al. <br/><span class="title">Role of ldb1 in adult intestinal homeostasis. [Journal Article, Research Support, N.I.H., Intramural]</span><br/><span class="source" title="International journal of biological sciences">Int J Biol Sci 2009; 5(7):686-94.</span><br/> <a href="http://www.unboundmedicine.com/medline/ebm/record/19918297/abstract/Role_of_ldb1_in_adult_intestinal_homeostasis_">Abstract</a> | <a href="http://www.unboundmedicine.com/medline/ebm/record/19918297/full_citation/Role_of_ldb1_in_adult_intestinal_homeostasis_">Full Citation</a></description></item><item><title>Role of GPR30 in the mechanisms of tamoxifen resistance in breast cancer MCF-7 cells.</title><link>http://www.unboundmedicine.com/medline/ebm/record/19911269/full_citation/Role_of_GPR30_in_the_mechanisms_of_tamoxifen_resistance_in_breast_cancer_MCF_7_cells_</link><description>Ignatov A, Ignatov T, Roessner A, et al. <br/><span class="title">Role of GPR30 in the mechanisms of tamoxifen resistance in breast cancer MCF-7 cells. [JOURNAL ARTICLE]</span><br/><span class="source" title="Breast cancer research and treatment">Breast Cancer Res Treat 2009 Nov 13.</span><br/> <a href="http://www.unboundmedicine.com/medline/ebm/record/19911269/abstract/Role_of_GPR30_in_the_mechanisms_of_tamoxifen_resistance_in_breast_cancer_MCF_7_cells_">Abstract</a> | <a href="http://www.unboundmedicine.com/medline/ebm/record/19911269/full_citation/Role_of_GPR30_in_the_mechanisms_of_tamoxifen_resistance_in_breast_cancer_MCF_7_cells_">Full Citation</a> | <a rel="nofollow" href="http://www.unboundmedicine.com/medline/ebm/related/19911269/Role_of_GPR30_in_the_mechanisms_of_tamoxifen_resistance_in_breast_cancer_MCF_7_cells_">Find Related Articles</a> </description></item><item><title>Retinal function in patients treated with tamoxifen.</title><link>http://www.unboundmedicine.com/medline/ebm/record/19911210/full_citation/Retinal_function_in_patients_treated_with_tamoxifen_</link><description>Watanabe SE, Berezovsky A, Motono M, et al. <br/><span class="title">Retinal function in patients treated with tamoxifen. [JOURNAL ARTICLE]</span><br/><span class="source" title="Documenta ophthalmologica. Advances in ophthalmology">Doc Ophthalmol 2009 Nov 13.</span><br/> <a href="http://www.unboundmedicine.com/medline/ebm/record/19911210/abstract/Retinal_function_in_patients_treated_with_tamoxifen_">Abstract</a> | <a href="http://www.unboundmedicine.com/medline/ebm/record/19911210/full_citation/Retinal_function_in_patients_treated_with_tamoxifen_">Full Citation</a> | <a rel="nofollow" href="http://www.unboundmedicine.com/medline/ebm/related/19911210/Retinal_function_in_patients_treated_with_tamoxifen_">Find Related Articles</a> </description></item></channel></rss>